Articles by Jim Miller - BioPharm International



Articles by Jim Miller

Outsourcing: Bio Building Boom

When it comes to biomanufacturing capacity, the rich are getting richer
Apr 1, 2006

Interestingly, it is companies that already have the most capacity available to them that are building even more.

Outsourcing: DSM Redefines its Biomanufacturing Strategy

Less capacity, more technology is the latest strategy adopted in contract biomanufacturing
Feb 1, 2006

Moving aggressively to implement its Vision 2010 strategy, which debuted in October 2005, DSM N.V. (Heerlen, Netherlands) announced in December 2005 that it would shut down its Montreal biomanufacturing facility in early 2006. The move doesn't signal an exit from manufacturing, however, but a change in focus; DSM will simultaneously expand its expression-technology relationship with Crucell (Leiden, the Netherlands). Both moves reflect changing circumstances in the biomanufacturing sector.

Outsourcing: All Eyes on Asia

CROs and CMOs in Asia offer a growing array of outsourcing opportunities for motivated biopharm companies.
Sep 1, 2005

In addition to India and China, other Asian countries are establishing themselves as destinations for biopharma companies.

Outsourcing: New Financial Realities Will Alter Biopharmaceutical Outsourcing Landscape

CROs and CMOs could face diminishing opportunities and escalating competition in the days ahead.
Jun 1, 2005

Avariety of forces are combining to fundamentally change the financial dynamics of the biopharmaceutical industry. The initial public offering (IPO) appears to be giving way to licensing arrangements with, and acquisitions by, major pharmaceutical companies.

Outsourcing: Early Development Services Lead the Way

2005 is shaping up as a big year for preclinical and clinical CROs, while contract manufacturers hope to see a reversal of a depressing four-year trend.
Feb 1, 2005

The contract manufacturing sector has not enjoyed the success of preclinical and clinical businesses.

Outsourcing Report: Contract Players

Contract biomanufacturing competition focuses on technology, not capacity.
Aug 1, 2004

Technology innovations aimed at increasing yields and shortening development times can be very cost-effective, promising to reduce the need for large capital investments while getting the client into the clinic much faster.

Outsourcing Report: Contract Biomanufacturers Turn Conservative,

Apr 1, 2004

Outsourcing Report

Outsourcing Report: Big Pharma Promises to Focus on Productivity

Feb 1, 2004

Current productivity initiatives may be too little, too late a more drastic overhaul may be required.

Outsourcing Outlook

All Signs Indicate a Strong 2004 for Contract Services
Dec 1, 2003

Publicly traded CROs and CMOs reported solid financial results in their most recent quarter, but the big news at October's AAPS meeting was the substantial rise in new RFPs and contracts.



Click here